A new report released by the Senate Homeland Security and Governmental Affairs Committee has revealed a concerning trend of worsening drug shortages in the United States, with new drug shortages increasing by nearly 30% from 2021 to 2022. The report identified three main causes of the shortages: economic drivers, reliance on foreign sources, and poor visibility of the pharmaceutical supply chain. The committee has called for more transparency in the pharmaceutical supply chain and for the government to take steps to address the underlying causes of the shortages.